Renascience Inc. (TYO:4889)

Japan flag Japan · Delayed Price · Currency is JPY
1,469.00
+14.00 (0.96%)
At close: Feb 6, 2026
22.42%
Market Cap19.46B +182.5%
Revenue (ttm)87.00M -32.6%
Net Income34.00M
EPS2.67
Shares Out13.25M
PE Ratio572.48
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume186,500
Average Volume192,045
Open1,450.00
Previous Close1,455.00
Day's Range1,418.00 - 1,473.00
52-Week Range868.00 - 3,310.00
Beta1.93
RSI43.23
Earnings DateFeb 13, 2026

About Renascience

Renascience Inc. engages in the development and commercialization of pharmaceuticals and medical devices in Japan. The company is developing RS5614, a PAI-1 inhibitor product candidate for use in the treatment of chronic myeloid leukemia, malignant melanoma, non-small cell lung cancer, cutaneous angio-sarcoma, coronavirus lung injury, and interstitial lung disease associated with systemic scleroderma; RS5441, PAI-1 inhibitor for the treatment of alopecia disease that is in Phase I clinical trials; and RS8001, a water-soluble vitamin for use in ... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2000
Employees 3
Stock Exchange Tokyo Stock Exchange
Ticker Symbol 4889
Full Company Profile

Financial Performance

Financial Statements